Two years later, Mao et al. prepared Trop2Fab-DOX conjugate that specifically binds to pancreatic cancer cells expressing Trop2, inhibiting their proliferation and migration in vitro and reducing the tumor growth in vivo [177]. This evidence concerns the gene TACSTD2 and neoplasm.